Thanks to Novartis (NVS), the investigations of President Trump and his minions now have a Big Pharma angle: The drug maker admitted to wiring monthly payments to a company controlled by the president’s lawyer — the same one that paid adult film star Stormy Daniels to keep quiet about an extramarital affair with Trump.

But in exchange for what? And who thought this was a good idea?

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • What was on Novartis mind to get involved with this crook?
    Makes me wonder about using any of their products!

  • The CEO alone can’t just write a monthly $100K check. The contract must have been reviewed by Novartis compliance lawyers who would protect the company by ensuring that the arrangement complied with Novartis’ corporate integrity agreement and would prohibit bribes, kickbacks, lobbying, and ensure that Novartis received value for dollar. This is not just a CEO’s handiwork. There must be a certain subtlety in the fine art of drug development, manufacturing and sales that I don’t appreciate. In principle, there is nothing Novartis should be concerned about, right?

  • Fascinating. How many employers do you know who give you a 12 month employment contract and then, months later, conduct the job interview and decide they don’t want your services, but you can keep the money?

  • What did Novartis get? Well, after just FOUR payments of $99,980 – an amount obviously designed to stay below a SOX reporting threshold – Jimenez got a personal meeting with Trump in Geneva. That meeting is a matter of public record. Ask Jimenez what they talked about, if he is not already lawyered up… and ask Novartis for all of Jimenez’ emails for the six weeks thereafter. If they are really being transparent, they will provide. If not, it’s a cover-up.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy